Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy

Clinical trials demonstrated intermittent preventive treatment in pregnancy with mefloquine (MQ) reduced malaria rates among pregnant women, yet an unexpected higher risk of mother-to-child transmission (MTCT) of HIV among HIV-positive women receiving MQ has also been observed. To determine if inter...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:AIDS Res Hum Retroviruses
Autori principali: Haaland, Richard E., Otieno, Kephas, Martin, Amy, Katana, Abraham, Dinh, Chuong, Slutsker, Laurence, Menendez, Clara, Gonzalez, Raquel, Williamson, John, Heneine, Walid, Desai, Meghna
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mary Ann Liebert, Inc., publishers 2018
Soggetti:
Clinical Trial
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6238614/
https://ncbi.nlm.nih.gov/pubmed/30173559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2018.0042
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi